# Documentation at	https://rdm.abcd-j.de/instructions.html#publications		
# bold fields are required			
citation	doi	url	date
Ingwersen, J., Masanneck, L., Pawlitzki, M. et al. Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials. Sci Rep 13, 15003 (2023).	https://doi.org/10.1038/s41598-023-40940-w	https://www.nature.com/articles/s41598-023-40940-w	2023-09-11